This Article Full Text Full Text (PDF) Supplemental material Other Versions of this Article: IAI.00176-07v1 75/10/4951    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Milam, J. E. Articles by Toews, G. B. Search for Related Content PubMed PubMed Citation Articles by Milam, J. E. Articles by Toews, G. B.

 Previous Article  |  Next Article 

Infection and Immunity, October 2007, p. 4951-4958, Vol. 75, No. 10
0019-9567/07/$08.00+0     doi:10.1128/IAI.00176-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Modulation of the Pulmonary Type 2 T-Cell Response to Cryptococcus neoformans by Intratracheal Delivery of a Tumor Necrosis Factor Alpha-Expressing Adenoviral Vector ^,

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine,¹ Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109²

Received 1 February 2007/ Returned for modification 11 March 2007/ Accepted 13 July 2007

C57BL/6 mice develop an allergic bronchopulmonary mycosis following intratracheal inoculation of Cryptococcus neoformans 24067. We determined that only low levels of tumor necrosis factor alpha (TNF-) are produced in the lungs following infection. Thus, the objective of the present studies was to determine whether treatment with a TNF--expressing adenoviral vector (adenoviral vector with the murine TNF- transgene under the control of the human cytomegalovirus promoter [AdTNF]) could switch the type 2 (T2) T-cell response/T1 T-cell response balance toward the T1 T-cell response. AdTNF induced an increase in TNF- expression at days 3 and 7. At days 7 to 14, the number of cryptococcal lung CFU continued to increase in both untreated and control adenoviral vector (empty adenovirus type 5 backbone)-treated mice, but the number was ultimately 100-fold lower following AdTNF treatment. AdTNF markedly increased neutrophil and macrophage numbers, and pulmonary eosinophilia did not develop. CXCL1, CXCL2, and gamma interferon were also up-regulated, while eotaxin, interleukin-4 (IL-4), and IL-5 were down-regulated. AdTNF treatment also increased the number of CD80⁺ and CD40⁺ cells and decreased the number of CD86⁺ cells (CD11b⁺ and CD11c⁺) in the lungs. Major histocompatibility complex class II levels on CD11b⁺ cells were increased. Whole-lung expression of inducible nitric oxide synthase was increased, while YM2 expression and acidic mammalian chitinase expression were decreased. None of these effects were observed with the control (empty) adenoviral vector. Overall, these results support the hypothesis that early TNF- expression promotes a shift in T-cell and macrophage polarization from T2/alternatively activated macrophages toward T1/classically activated macrophages, resulting in control of the fungal infection and prevention of the allergic response.

Published ahead of print on 23 July 2007.

Supplemental material for this article may be found at http://iai.asm.org/.

Editor: A. Casadevall

This article has been cited by other articles:

• Chen, G.-h., McNamara, D. A., Hernandez, Y., Huffnagle, G. B., Toews, G. B., Olszewski, M. A. (2008). Inheritance of Immune Polarization Patterns Is Linked to Resistance versus Susceptibility to Cryptococcus neoformans in a Mouse Model. Infect. Immun. 76: 2379-2391 [Abstract] [Full Text]